HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rama Natarajan Selected Research

4- (3- (biotinylaminohexamethylenaminocarbonyl)propanoylaminomethyl)- 2- methyl- 1,3- dithiolane- 2- yl- (Ala(7))phalloidin

1/200512/15-lipoxygenase inhibitors in diabetic nephropathy in the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rama Natarajan Research Topics

Disease

30Diabetic Nephropathies (Diabetic Nephropathy)
01/2019 - 11/2003
20Diabetes Complications
01/2021 - 05/2003
16Hypertrophy
01/2018 - 03/2002
16Atherosclerosis
11/2017 - 06/2003
12Inflammation (Inflammations)
01/2022 - 04/2003
11Hypertension (High Blood Pressure)
10/2021 - 04/2003
8Diabetic Angiopathies (Diabetic Angiopathy)
01/2021 - 09/2003
8Hyperglycemia
11/2020 - 05/2006
8Proteinuria
01/2016 - 03/2005
7Fibrosis (Cirrhosis)
01/2022 - 07/2009
7Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021 - 10/2006
6Diabetes Mellitus
10/2020 - 01/2005
6Obesity
01/2020 - 04/2005
6Kidney Diseases (Kidney Disease)
01/2016 - 04/2003
5Albuminuria
05/2016 - 01/2005
4Cardiovascular Diseases (Cardiovascular Disease)
12/2018 - 01/2005
4Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2013 - 07/2004
3Neoplasms (Cancer)
12/2021 - 12/2014
3Insulin Resistance
01/2020 - 04/2005
3Chronic Renal Insufficiency
08/2015 - 05/2011
3Vascular Diseases (Vascular Disease)
05/2014 - 10/2005
2Type 2 Diabetes Mellitus (MODY)
11/2020 - 10/2007
2Breast Neoplasms (Breast Cancer)
01/2020 - 01/2020
2Dyslipidemias (Dyslipidemia)
03/2016 - 09/2013
2Polycystic Kidney Diseases (Polycystic Kidney Disease)
01/2016 - 05/2011
2Disease Progression
07/2015 - 05/2007
1Weight Gain
01/2022
1Glucose Intolerance
01/2022
1Carcinogenesis
12/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2021
1Hypoxia (Hypoxemia)
01/2020
1Acute Kidney Injury (Acute Renal Failure)
01/2016
1Lupus Nephritis
01/2016
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2016
1Disease Susceptibility (Diathesis)
01/2016

Drug/Important Bio-Agent (IBA)

23MicroRNAs (MicroRNA)IBA
01/2020 - 07/2009
12Histones (Histone)IBA
01/2022 - 05/2007
12Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 04/2003
12Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA
03/2016 - 06/2003
11ChromatinIBA
01/2022 - 05/2007
11CytokinesIBA
01/2021 - 05/2003
9Glucose (Dextrose)FDA LinkGeneric
01/2021 - 12/2003
9Proteins (Proteins, Gene)FDA Link
05/2016 - 03/2002
8Biomarkers (Surrogate Marker)IBA
12/2021 - 05/2011
8Angiotensin IIIBA
12/2018 - 03/2002
8Advanced Glycation End ProductsIBA
09/2013 - 09/2003
7Long Noncoding RNAIBA
10/2021 - 12/2014
7Oxidants (Oxidizing Agents)IBA
03/2016 - 04/2003
6LipidsIBA
03/2016 - 03/2002
6Streptozocin (Streptozotocin)FDA Link
01/2016 - 03/2005
6EnzymesIBA
01/2016 - 11/2003
5AcidsIBA
03/2016 - 03/2002
5CollagenIBA
12/2014 - 12/2003
5Lysine (L-Lysine)FDA Link
02/2014 - 05/2007
5ChemokinesIBA
09/2013 - 05/2003
4Extracellular Matrix ProteinsIBA
09/2015 - 12/2006
3Interleukin-6 (Interleukin 6)IBA
12/2018 - 05/2006
3Hydroxyeicosatetraenoic Acids (HETE)IBA
03/2016 - 04/2003
3Biological ProductsIBA
01/2016 - 12/2008
3LigandsIBA
12/2014 - 05/2006
3Fibronectins (Fibronectin)IBA
03/2012 - 03/2002
3Transforming Growth Factor beta (TGF-beta)IBA
07/2009 - 12/2008
3p38 Mitogen-Activated Protein KinasesIBA
12/2008 - 03/2002
3NF-kappa B (NF-kB)IBA
12/2008 - 07/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2008 - 05/2006
3Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA
01/2005 - 03/2002
3Lipoxygenase (Lipoxygenase-1)IBA
11/2003 - 03/2002
2Pharmaceutical PreparationsIBA
01/2021 - 03/2015
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 05/2016
2Insulin (Novolin)FDA Link
01/2020 - 12/2014
2oxidized low density lipoproteinIBA
01/2020 - 01/2012
2OligonucleotidesIBA
09/2016 - 10/2007
2Transcription Factors (Transcription Factor)IBA
01/2016 - 06/2003
2alpha2 Subunit Collagen Type IIBA
12/2014 - 10/2010
2Receptor for Advanced Glycation End ProductsIBA
12/2014 - 05/2006
2Losartan (Cozaar)FDA LinkGeneric
02/2014 - 04/2005
2Transforming Growth Factors (Transforming Growth Factor)IBA
09/2013 - 05/2012
2Phosphotransferases (Kinase)IBA
08/2013 - 07/2009
2CreatinineIBA
05/2011 - 10/2007
2Quinapril (Accupril)FDA LinkGeneric
01/2007 - 07/2004
2Interferon-gamma (Interferon, gamma)IBA
10/2006 - 05/2006
2Interleukin-18 (Interleukin 18)IBA
05/2006 - 05/2005
2Arachidonic Acid (Vitamin F)IBA
04/2003 - 03/2002
1Metformin (Glucophage)FDA LinkGeneric
01/2022
1KinesinsIBA
12/2021
1Nonesterified Fatty Acids (NEFA)IBA
01/2021
1AutoantigensIBA
01/2021
1Hormones (Hormone)IBA
01/2020
1SugarsIBA
01/2020
1Environmental CarcinogensIBA
01/2020
1FatsIBA
01/2020
1Food Additives (Food Additive)IBA
01/2020
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2020
1Endocrine DisruptorsIBA
01/2020
1NucleolinIBA
01/2018
1Mono-SIBA
05/2016
1ThioredoxinsIBA
05/2016
1InflammasomesIBA
01/2016

Therapy/Procedure

13Therapeutics
01/2021 - 01/2007
8Glycemic Control
11/2020 - 07/2008